Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Terminated 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4Head & Neck 3Thoracic 2Gastrointestinal 2Sarcoma 1Gynecologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 24Ovarian Neoplasms 16Lung Neoplasms 15Breast Neoplasms 14Endometrial Neoplasms 13Parkinson Disease 4, Autosomal Dominant Lewy Body 12Fallopian Tube Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Neoplasm Metastasis 8Triple Negative Breast Neoplasms 5Esophageal Neoplasms 5Adenocarcinoma Of Esophagus 5Stomach Neoplasms 4Neoplasms 4Melanoma 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 3Carcinoma 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Peritoneal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Brenner Tumor 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Solid Tumour 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Adenocarcinoma 2Uterine Neoplasms 1

Interventions

Nivolumab 21pembrolizumab 19Ipilimumab 14Specimen Handling 12Magnetic Resonance Spectroscopy 7Opdualag 6CTLA-4 Antigen 6relatlimab 5binimetinib 5trametinib 4Paclitaxel 4dabrafenib 3Taxes 3Standard of Care 3Pemetrexed 3Introns 3Interferon alpha-2 3Gemcitabine 3Carboplatin 3Blood Specimen Collection 3ulixertinib 2sargramostim 2lifileucel 2lenvatinib 2fludarabine phosphate 2fludarabine 2encorafenib 2capivasertib 2cabozantinib 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Melanoma × Paclitaxel × 30 days × Clear all
NCT04083599 2026-06-02

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Genmab

Phase 1/2 Active not recruiting
350 enrolled
DermatologicGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms

NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

NCT07492680 2026-05-29

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Bristol-Myers Squibb

Phase 2 Not yet recruiting
260 enrolled
CNSDermatologicGastrointestinal

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

NCT03645928 2026-05-15

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Iovance Biotherapeutics, Inc.

Phase 2 Terminated
225 enrolled
DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡